| scholarly article | Q13442814 |
| P50 | author | Rainer Fietkau | Q64584867 |
| Benjamin Frey | Q38326649 | ||
| P2093 | author name string | Udo S Gaipl | |
| Josefin Hartmann | |||
| Anja Derer | |||
| Lisa Deloch | |||
| P2860 | cites work | Low and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti-inflammatory cytokine milieu, but do not impact upon viability and phagocytic function | Q87677634 |
| Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade | Q50777923 | ||
| Volumetric modulated arc therapy: IMRT in a single gantry arc. | Q51892378 | ||
| Albert soiland and the early development of therapeutic radiology in the united states | Q52411163 | ||
| Equivalent total doses for different fractionation schemes, based on the linear quadratic model | Q52450471 | ||
| Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units | Q53120652 | ||
| Radio-immunotherapy: the focused beam expands | Q53460332 | ||
| Radiation oncology: a century of achievements. | Q55038981 | ||
| A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 | Q56532851 | ||
| Immunosuppressive effects of apoptotic cells | Q59060221 | ||
| Die Rolle der Strahlentherapie bei der Induktion von Antitumor-Immunantworten | Q61893824 | ||
| Die stereotaktische Strahlentherapie unterstützt die Immunantwort | Q64030451 | ||
| The Effect of Multiple Small Doses of X Rays on Skin Reactions in the Mouse and a Basic Interpretation | Q67446378 | ||
| Optimization of stationary and moving beam radiation therapy techniques | Q68476822 | ||
| [Therapeutic efficacy of pre-operative radiotherapy on breast carcinoma: in special reference to its abscopal effect on metastatic lymph-nodes] | Q68915671 | ||
| Comparative study of results obtained with conventional radiotherapy (200 KV) and cobalt therapy in the treatment of cancer of the larynx | Q72230885 | ||
| The Abscopal Effect in Malignant Lymphoma and Its Relationship to Lymphocyte Circulation | Q72535440 | ||
| Combination of ?-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: Approach to treatment of advanced stage cancer | Q77357816 | ||
| Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment | Q79342882 | ||
| Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration | Q79370218 | ||
| Stereotactic body radiotherapy for oligometastatic lung tumors | Q80976956 | ||
| Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases | Q82288170 | ||
| Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy | Q87499954 | ||
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 | Q24653924 | ||
| Targeting the Mitotic Catastrophe Signaling Pathway in Cancer | Q26778544 | ||
| Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications | Q26779221 | ||
| The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? | Q26823489 | ||
| Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice | Q27015651 | ||
| Radiotherapy and the tumor stroma: the importance of dose and fractionation | Q27022685 | ||
| Death and anti-death: tumour resistance to apoptosis | Q28217065 | ||
| Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated | Q28245528 | ||
| DNA damage and the balance between survival and death in cancer biology | Q28271163 | ||
| Past, present, and future of radiotherapy for the benefit of patients | Q28280008 | ||
| Signatures of mutational processes in human cancer | Q29547191 | ||
| How does radiation kill cells? | Q33533818 | ||
| Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens. | Q33878572 | ||
| Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. | Q33930593 | ||
| Radiation-induced apoptosis | Q33992363 | ||
| Radiation therapy: state of the art and the future | Q34105161 | ||
| Radiation-induced cell death mechanisms | Q34116777 | ||
| Necrosis: a specific form of programmed cell death? | Q34174765 | ||
| The sensitivity of lymphocytes to ionising radiation | Q34231156 | ||
| The role of biologically effective dose (BED) in clinical oncology | Q34262045 | ||
| ??? | Q95395760 | ||
| Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells. | Q34373081 | ||
| Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells | Q34438000 | ||
| Combinations of immunotherapy and radiation in cancer therapy. | Q34582640 | ||
| Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells | Q34682107 | ||
| Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen | Q35328111 | ||
| Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy | Q35540109 | ||
| Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress | Q35641503 | ||
| Maximizing Tumor Immunity With Fractionated Radiation | Q35916615 | ||
| Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions | Q35958252 | ||
| The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation | Q36069982 | ||
| The controversial abscopal effect | Q36143531 | ||
| Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer | Q36332315 | ||
| Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. | Q36430737 | ||
| Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer | Q36476394 | ||
| Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis | Q36584651 | ||
| Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming | Q36616735 | ||
| Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy | Q36829161 | ||
| Clearance of apoptotic cells by phagocytes | Q36850155 | ||
| Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. | Q36874767 | ||
| Many faces of DAMPs in cancer therapy | Q36907117 | ||
| Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype | Q37162103 | ||
| Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment | Q37268974 | ||
| Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody | Q37351567 | ||
| Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer | Q37468265 | ||
| STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. | Q37502349 | ||
| Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. | Q37524200 | ||
| Systemic effects of local radiotherapy | Q37539309 | ||
| Current concepts in clinical radiation oncology | Q37603804 | ||
| Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy | Q37670422 | ||
| Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS) | Q37974257 | ||
| Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies. | Q37993183 | ||
| How does ionizing irradiation contribute to the induction of anti-tumor immunity? | Q38030920 | ||
| Effects of ionizing radiation on the immune system with special emphasis on the interaction of dendritic and T cells. | Q38039442 | ||
| Dying cell clearance and its impact on the outcome of tumor radiotherapy | Q38042950 | ||
| Apoptosis in radiation therapy: a double-edged sword | Q38052398 | ||
| Contribution of the immune system to bystander and non-targeted effects of ionizing radiation | Q38153979 | ||
| The four faces of autophagy: implications for cancer therapy | Q38181453 | ||
| Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy | Q38217593 | ||
| The autophagic response to radiation: relevance for radiation sensitization in cancer therapy | Q38245753 | ||
| Radiotherapy and immunogenic cell death | Q38284085 | ||
| Myeloid-derived cells in tumors: effects of radiation | Q38284087 | ||
| Building immunity to cancer with radiation therapy | Q38319687 | ||
| Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy | Q38331755 | ||
| Lung cancer: the immune system and radiation. | Q38540827 | ||
| Anthracyclines induce DNA damage response-mediated protection against severe sepsis. | Q38549117 | ||
| Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors | Q38641806 | ||
| Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines | Q38868168 | ||
| PD-1 Restrains Radiotherapy-Induced Abscopal Effect. | Q38907646 | ||
| Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells | Q39025449 | ||
| Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor | Q39169737 | ||
| Turning T cells on: epigenetically enhanced expression of effector T-cell costimulatory molecules on irradiated human tumor cells | Q39575992 | ||
| Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies | Q39650657 | ||
| Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation | Q39957013 | ||
| Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. | Q40144504 | ||
| Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. | Q40251054 | ||
| Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor | Q40412166 | ||
| Radiation-induced apoptosis: Relevance to radiotherapy | Q40433820 | ||
| Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study. | Q41034587 | ||
| Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. | Q41653193 | ||
| Interpretation of some results from radiotherapy and an attempt to determine a rational treatment technique. 1906. | Q42030151 | ||
| Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report | Q42062177 | ||
| Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death | Q42115292 | ||
| Fears over radiotherapy fractionation regimens in breast cancer. Proposed Uk trial needs to define techniques as well as numbers of treatments | Q42757647 | ||
| Trial Watch: Radioimmunotherapy for oncological indications | Q43104064 | ||
| Local irradiation of murine melanoma affects the development of tumour-specific immunity. | Q46022196 | ||
| Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis | Q46159777 | ||
| Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. | Q46248787 | ||
| The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. | Q46425805 | ||
| Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy | Q46502316 | ||
| Radiation abscopal antitumor effect is mediated through p53 | Q47965289 | ||
| Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction | Q48035956 | ||
| Nomenclature of modified fractionation protocols in radiotherapy | Q48785691 | ||
| The characterization of tumor apoptosis after experimental radiosurgery | Q48962259 | ||
| Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. | Q50736160 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 141 | |
| P577 | publication date | 2016-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation | |
| P478 | volume | 6 |
| Q91657409 | 13-Ethylberberine Induces Apoptosis through the Mitochondria-Related Apoptotic Pathway in Radiotherapy-Resistant Breast Cancer Cells |
| Q32177609 | A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response |
| Q49553757 | Abscopal effect of radiation on bone metastases of breast cancer: A case report |
| Q51009327 | Active caspase-3 expression levels as bioindicator of individual radiosensitivity |
| Q57813529 | An Anti-Tumor Immune Response is Evoked By Partial-Volume Single Dose Radiation in Two Murine Models |
| Q37525422 | Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells |
| Q59808906 | Clinically Relevant Radiation Exposure Differentially Impacts Forms of Cell Death in Human Cells of the Innate and Adaptive Immune System |
| Q89027169 | Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects |
| Q60922811 | Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle |
| Q89835376 | Combination of Gas Plasma and Radiotherapy Has Immunostimulatory Potential and Additive Toxicity in Murine Melanoma Cells in Vitro |
| Q64374693 | Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models |
| Q38788456 | Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients. |
| Q91871648 | Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology |
| Q59329233 | Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium |
| Q91559163 | Fractionated head and neck irradiation impacts taste progenitors, differentiated taste cells, and Wnt/β-catenin signaling in adult mice |
| Q37685388 | Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors. |
| Q92741127 | Immune biological rationales for the design of combined radio- and immunotherapies |
| Q87944374 | Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies |
| Q58796914 | Immunologically effective dose: a practical model for immuno-radiotherapy |
| Q48193685 | Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. |
| Q38632924 | Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection |
| Q55385538 | Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis. |
| Q89967597 | Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer |
| Q90263787 | Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol |
| Q55473791 | Personalizing Radiation Treatment Delivery in the Management of Breast Cancer. |
| Q39402079 | Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer. |
| Q59126168 | Radiation therapy and immunotherapy—a potential combination in cancer treatment |
| Q59806702 | Radiotherapy and immune response: the systemic effects of a local treatment |
| Q99552006 | Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancer |
| Q52886428 | Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer |
| Q47880159 | Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. |
| Q91899217 | Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response |
| Q39172554 | Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity |
| Q47558991 | TARGETED AND OFF-TARGET (BYSTANDER AND ABSCOPAL) EFFECTS OF RADIATION THERAPY: REDOX MECHANISMS AND RISK-BENEFIT ANALYSIS. |
| Q37625801 | The Immunoregulatory Potential of Particle Radiation in Cancer Therapy |
| Q50307416 | Treatment of late sequelae after radiotherapy for head and neck cancer |
Search more.